Remove tag sec
article thumbnail

Can gene therapies for haemophilia defend their high price tags?

Pharmaceutical Technology

In its October 28 quarterly Securities and Exchange Commission (SEC) filing, the company said that Roctavian’s commercial launch is now underway. million price tag. The post Can gene therapies for haemophilia defend their high price tags? BioMarin previously said that the treatment’s European price would likely be around EUR1.5

article thumbnail

Merck Announces Withdrawal and Refiling under the Hart-Scott-Rodino Act and Extension of Tender Offer to.

The Pharma Data

Merck has tagged to withdraw its Premerger Notification and Report Form, which was originally filed on October 14, 2021, to give the Federal Trade Commission (the “ FTC”) with fresh time for review, and expects to refile similar form on or about November 1, 2021. Securities and Exchange Commission (the “ SEC”). About Merck.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Axsome bounces back as FDA clears depression drug

pharmaphorum

The biotech hasn’t revealed much information about the reasons for the delay in getting approval, but said in an SEC filing in June this year that it had agreed to “post-marketing commitments” proposed by the FDA, without going into details.

Drugs 98
article thumbnail

Clover and Dynavax Announce Planned Global Phase 2/3 Efficacy Trial of Adjuvanted COVID-19 Vaccine Candidate

The Pharma Data

Utilizing Clover’s proprietary Trimer-Tag© technology, S-Trimer is a trimeric SARS-CoV-2 spike (S)-protein subunit vaccine candidate. About Trimer-Tag© Technology. Trimer-Tag© is an innovative drug development platform which allows the production of novel, covalently-trimerized fusion proteins.